Your browser doesn't support javascript.
loading
Reply to Zhu et al.: Implications of CHRNB1 and ERBB2 in the pathobiology of myasthenia gravis.
Chia, Ruth; Saez-Atienzar, Sara; Drachman, Daniel B; Traynor, Bryan J.
Afiliação
  • Chia R; Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD 20892.
  • Saez-Atienzar S; Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD 20892.
  • Drachman DB; Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD 21287.
  • Traynor BJ; Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD 20892.
Proc Natl Acad Sci U S A ; 119(36): e2209096119, 2022 09 09.
Article em En | MEDLINE | ID: mdl-35969799

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores Nicotínicos / Receptor ErbB-2 / Miastenia Gravis Limite: Humans Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores Nicotínicos / Receptor ErbB-2 / Miastenia Gravis Limite: Humans Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2022 Tipo de documento: Article